Everything You Need to Know About Transdermal Patches
Tapemark’s proprietary iontophoresis patches and other types of transdermal patches offer many advantages to drug developers, prescribers, and patients.
Read More7 Surprising Facts About the Pharmaceutical Industry
From clinical manufacturing to clinical distribution, the pharmaceutical production process is vast. See just how big of an impact the industry has today.
Read MoreExploring Innovation and the Vast Potential of Transdermal Patch Drug Delivery
Beau Garrett, Senior Vice President and Chief Operating Officer of Tapemark, discusses the current state of the industry with regard to transdermal patch drug delivery.
Read MoreTapemark Selected as Minnesota Manufacturing Awards Honoree by Minneapolis/St. Paul Business Journal
Tapemark announced as one of the Minneapolis St. Paul Business Journal's 2021 Minnesota Manufacturing Awards honorees.
Read MoreTapemark and 10x Technology Announce Strategic Partnership to Commercialize MicroDerm
The MicroDerm microneedle transdermal system provides a new solution. The patch penetrates the skin just enough to enable the drug to enter the bloodstream
Read MoreTapemark and Biotts Partner to Create MacroPerm™ for Large-Molecule Transdermal Drug Delivery
Tapemark and Biotts announce a partnership to commercialize MacroPerm™, a large-molecule transdermal technology designed to transport API through the skin.
Read MoreTapemark Manufacturing Facility Completes Successful FDA Pre-Approval and General GMP Inspection
The FDA has completed a successful pre-approval inspection (PAI) of Tapemark’s manufacturing process and a general good manufacturing practices (GMP) inspection.
Read MoreFinding Your Niche as a CDMO – Pharmaceutical Processing Features Tapemark in November/December 2016 Issue
Each print issue of Pharmaceutical Processing features a CDMO in its cover story. This month’s issue showcases Tapemark.
Read More